fda semaglutide warning news october 2025 U.S. | The FDA has approved a new higher dose (7.2 mg) of Wegovy ( semaglutide) injection, Wegovy HD, for weight loss and long-term weight Wegovy® Lawsuit | July 2026

GLP-1 Receptor Agonists May Reduce Rheumatoid Arthritis Activity and Cardiovascular Risk in People with Obesity Key Takeaways: GLP-1 receptor agonists were linked to reduced rheumatoid arthritis (RA) disease activity and improved cardiovascular risk factors in people with obesity or overweight

We also need to know that 1 mL of liquid is the same as 100 units on a standard insulin syringe

It is simple division

Third-party testing is non-negotiable if youre serious about safety and efficacy

Profile photos can add a personal touch to websites, Linkedin business page and printed sales material

Storage & Handling: Store at -20C for long-term stability Avoid repeated freezethaw cycles Handle using appropriate laboratory PPE Research Handling Note: For best results in a research setting, allow both: the peptide and chosen solvent to reach ambient laboratory temperature before reconstitution